Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rakool Pharmaceutical Marketing Co., Ltd. is a specialized Japanese pharmaceutical company that develops, markets, and distributes external medicinal preparations and healthcare products. As the core sales arm of the Rakool Group, the company provides a wide range of topical treatments, including analgesics, dermatological ointments, and medicated skincare. Its flagship product lines include the Rakupetan and Rokupufen series of transdermal patches (plasters) used for musculoskeletal pain and inflammation. Rakool operates in both the prescription and over-the-counter (OTC) markets, supported by its manufacturing affiliate, Toko Pharmaceutical Industries, which provides research and development for its patch technology. The company is headquartered in Tokyo and maintains several regional offices and a distribution center to serve the Japanese healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rakool Pharmaceutical.